ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2022

Non-small Cell Lung Cancer with EGFR or HER2 Exon 20 Insertion Mutations: Diagnosis and Treatment Options.

Danielle Brazel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.